Inovalon (NASDAQ:INOV) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.
Several other brokerages also recently commented on INOV. KeyCorp restated a “hold” rating on shares of Inovalon in a research report on Tuesday, September 12th. TheStreet upgraded Inovalon from a “d+” rating to a “c-” rating in a research report on Thursday, October 5th. Morgan Stanley upgraded Inovalon from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $9.00 to $14.00 in a research report on Tuesday, September 12th. ValuEngine upgraded Inovalon from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Finally, Zacks Investment Research downgraded Inovalon from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $14.00.
Inovalon (NASDAQ INOV) opened at $15.60 on Friday. Inovalon has a 52-week low of $8.60 and a 52-week high of $17.80. The company has a market capitalization of $2,275.60, a PE ratio of 74.29, a PEG ratio of 4.57 and a beta of 1.24. The company has a debt-to-equity ratio of 0.31, a current ratio of 5.62 and a quick ratio of 5.62.
In other news, CEO Keith R. Dunleavy bought 62,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were bought at an average cost of $16.38 per share, for a total transaction of $1,015,560.00. Following the completion of the transaction, the chief executive officer now owns 270,000 shares of the company’s stock, valued at $4,422,600. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Shauna L. Vernal sold 5,908 shares of the business’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $16.01, for a total value of $94,587.08. Following the completion of the sale, the insider now owns 47,309 shares in the company, valued at $757,417.09. The disclosure for this sale can be found here. 48.28% of the stock is currently owned by insiders.
Several large investors have recently bought and sold shares of INOV. BNP Paribas Arbitrage SA raised its position in Inovalon by 336.2% during the second quarter. BNP Paribas Arbitrage SA now owns 8,397 shares of the technology company’s stock valued at $110,000 after purchasing an additional 6,472 shares during the period. Advisor Group Inc. raised its position in Inovalon by 24.8% during the second quarter. Advisor Group Inc. now owns 10,191 shares of the technology company’s stock valued at $134,000 after purchasing an additional 2,023 shares during the period. Virtu KCG Holdings LLC purchased a new stake in Inovalon during the second quarter valued at approximately $154,000. Principal Financial Group Inc. purchased a new stake in Inovalon during the second quarter valued at approximately $157,000. Finally, Bank of Montreal Can raised its position in Inovalon by 0.4% during the second quarter. Bank of Montreal Can now owns 14,006 shares of the technology company’s stock valued at $184,000 after purchasing an additional 61 shares during the period. Institutional investors own 28.14% of the company’s stock.
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
What are top analysts saying about Inovalon Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Inovalon Holdings Inc. and related companies.